$30.58
-0.20-0.65%
At close: -
$30.36
-0.22-0.72%
After Hours: Feb 25, 7:48 AM EDT
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Tema GLP-1, Obesity & Cardiometabolic ETF Stock Price, Quotes and Forecasts
HRTSNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
67.50M
Fund Score
Tema GLP-1, Obesity & Cardiometabolic ETF Price, Quotes and Forecasts | NASDAQ:HRTS | Benzinga
Explore Tema GLP-1, Obesity & Cardiometabolic ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HRTS.
| Open | $30.92 |
| High | $30.92 |
| 52 Wk High | $36.03 |
| AUM | 67.50M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 4.17K |
| Market Cap | $64.23B |
| Mgmt Fee | 0.99% |
| P/E Ratio | 37.15 |
| Prev. Close | $30.78 |
| Low | $30.52 |
| 52 Wk Low | $28.56 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | - |
| Beta | - |
| Avg. Expense Ratio | 0.75% |
| P/B Ratio | 5.29 |
Recent News
FAQ
Q
How do I buy Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) stock?
A
You can purchase shares of Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS) through any online brokerage.
Q
Who are Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) competitors?
A
There are no as such competitors for Tema GLP-1, Obesity & Cardiometabolic ETF.
Q
What is the forecast, or price target, for Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) stock?
A
There is no analysis for Tema GLP-1, Obesity & Cardiometabolic ETF to provide a consensus price target.
Q
What is the current price for Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS)?
A
The stock price for Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ: HRTS) is $30.36 last updated February 25, 2025 at 7:48 AM EST.
Q
Does Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) pay a dividend?
A
There are no upcoming dividends for Tema GLP-1, Obesity & Cardiometabolic ETF.
Q
When is Tema GLP-1, Obesity & Cardiometabolic ETF (NASDAQ:HRTS) reporting earnings?
A
Tema GLP-1, Obesity & Cardiometabolic ETF does not have any upcoming earnings scheduled.
Q
Is Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) going to split?
A
There is no upcoming split for Tema GLP-1, Obesity & Cardiometabolic ETF.
| Open | $30.92 |
| High | $30.92 |
| 52 Wk High | $36.03 |
| AUM | 67.50M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 4.17K |
| Market Cap | $64.23B |
| Mgmt Fee | 0.99% |
| P/E Ratio | 37.15 |
| Prev. Close | $30.78 |
| Low | $30.52 |
| 52 Wk Low | $28.56 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | - |
| Beta | - |
| Avg. Expense Ratio | 0.75% |
| P/B Ratio | 5.29 |
About Tema ETF Trust
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | - |
| Investment Style | Large Cap Blend |
| Fund Inception | Nov 20, 2023 |
| Managers | Ryan Houlton Troy Cates Garrett Paolella Yuri Khodjamirian David Song |
| Definition | - |
Investment Policy
The investment seeks to provide long-term growth of capital by investing in companies leading the fight against diabetes, obesity and cardiovascular diseases. Obesity is on the cusp of a revolution in therapeutics, while heart disease, the most common cause of death, is witnessing a renaissance of therapies driven by genetic insights and tools.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2025 Benzinga | All Rights Reserved